BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
06 juil. 2023 04h00 HE
|
AKAMPION
Market entry under new EU regulations for medical devicesSpearheading the commercialization of 3D-printed regenerative medicine products Leipzig, Germany, July 6, 2023 – BellaSeno GmbH, an ISO...
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
06 juil. 2023 04h00 HE
|
AKAMPION
Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A...
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
05 juil. 2023 04h00 HE
|
AKAMPION
- Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off PRESS RELEASE. Cologne, Germany — July 05, 2023 - Cellbox Solutions GmbH, a leading provider of warm...
Oliver Healthcare Packaging stärkt seine Lieferkette und erweitert regionale Film- und Folienproduktion
29 juin 2023 03h00 HE
|
AKAMPION
-- Übernahme von EK-Pack stellt die neueste Investition zur Stärkung des Engagements für Kunden in ganz Europa dar. Philadelphia, USA, und Wiggensbach, Deutschland (29. Juni 2023) - Oliver...
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
29 juin 2023 03h00 HE
|
AKAMPION
-- Acquisition of EK-Pack latest investment to bolster commitment to customers throughout Europe. Philadelphia, United States, AND Wiggensbach, Germany (29 June 2023) – Oliver Healthcare...
Dopavision gibt Update zur klinischen Studie mit MyopiaX® bekannt; alle Studienzentren aktiv
28 juin 2023 04h00 HE
|
AKAMPION
- Klinische Erprobung von MyopiaX®, dem ersten Ansatz zur digitalen Behandlung von Kurzsichtigkeit bei Kindern beruhend auf dem Dopamin-Signalweg - Aufnahme von Patienten in Deutschland, Spanien,...
Dopavision proporciona información actualizada sobre los ensayos clínicos y anuncia que todos los centros del ensayo MyopiaX-1 están activos
28 juin 2023 04h00 HE
|
AKAMPION
- Primer ensayo clínico en humanos de MyopiaX® , el primer enfoque terapéutico para la miopía juvenil dirigido digitalmente a la vía dopaminérgica.- Inscripción en curso en Alemania, España, Países...
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
28 juin 2023 04h00 HE
|
AKAMPION
- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the Netherlands, and the...
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
20 juin 2023 04h00 HE
|
AKAMPION
IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...
BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction
20 juin 2023 04h00 HE
|
AKAMPION
Data presented at the 24th EFFORT Congress in Vienna (Austria) Leipzig, Germany, June 20, 2023 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using...